NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.99 -0.01 (-0.01%) GOLD FUTURES
2,315.00 +4.00 (+0.17%) DOW
38,155.17 +251.88 (+0.66%) Bitcoin GBP
47,313.14 +1,437.19 (+3.13%)
NVO Jan 2025 100.000 put
| Previous close | 2.8700 |
| Open | 2.8500 |
| Bid | 3.0500 |
| Ask | 3.1500 |
| Strike | 100.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.8500 - 2.8700 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.09k |
Yahoo FinanceNovo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
Barrons.comNovo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.
